Neurological Surgery 脳神経外科50巻2号

2022年03月発行

特集 水頭症—脳脊髄液動態への理解と治療に迫る Ⅱ特発性正常圧水頭症

特発性正常圧水頭症（iNPH）の診断

著者： 中島円¹ 川村海渡¹

所属機関： ¹順天堂大学脳神経外科

ページ範囲：P.298 - P.308

Point
・『特発性正常圧水頭症（iNPH）診療ガイドライン第3版』（GL 2020）では，iNPHの診断を症候，画像所見とタップテスト判定を中核にし，シャント治療が有効な患者群を抽出している．
・GL 2020の診断アルゴリズムは，iNPHの症状に類似する疾患との鑑別プロセスが含まれていないため，アルゴリズムに含まれない検査は詳細な疾患病態や併存疾患の程度を捉える目的で実施される．

参考文献

1）Hakim S, Adams RD：The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2：307-327, 1965

2）Hashimoto M, et al；Study of INPH on neurological improvement（SINPHONI）：Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme：a prospective cohort study. Cerebrospinal Fluid Res 7：18, 2010

3）Andersson J, et al：Prevalence of idiopathic normal pressure hydrocephalus：a prospective, population-based study. PLoS One 14：e0217705, 2019

4）Kameda M, et al；SINPHONI and SINPHONI-2 Investigators：Cost-effectiveness analysis of shunt surgery for idiopathic normal pressure hydrocephalus based on the SINPHONI and SINPHONI-2 trials. Acta Neurochir（Wien）159：995-1003, 2017

5）Ishikawa M, et al：Improvement in the long-term care burden after surgical treatment of patients with idiopathic normal pressure hydrocephalus：a supplementary study. Sci Rep 11：11732, 2021

6）Ishikawa M；Guideline Committe for Idiopathic Normal Pressure Hydrocephalus, Japanese Society of Normal Pressure Hydrocephalus：Clinical guidelines for idiopathic normal pressure hydrocephalus. Neurol Med Chir（Tokyo）44：222-223, 2004

7）Ishikawa M, et al：Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol Med Chir（Tokyo）48（Suppl）：S1-23, 2008

8）Marmarou A, et al：Development of guidelines for idiopathic normal-pressure hydrocephalus：introduction. Neurosurgery 57（3 Suppl）：S1-3；discussion ii-v, 2005

9）Marmarou A, et al：The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 57（3 Suppl）：S17-28；discussion ii-v, 2005

10）Kitagaki H, et al：CSF spaces in idiopathic normal pressure hydrocephalus：morphology and volumetry. AJNR Am J Neuroradiol 19：1277-1284, 1998

11）Yamada S, et al：Optimal diagnostic indices for idiopathic normal pressure hydrocephalus based on the 3D quantitative volumetric analysis for the cerebral ventricle and subarachnoid space. AJNR Am J Neuroradiol 36：2262-2269, 2015

12）Yamada S, et al：Comparison of CSF distribution between idiopathic normal pressure hydrocephalus and Alzheimer disease. AJNR Am J Neuroradiol 37：1249-1255, 2016

13）Kamiya K, et al：Diffusion imaging of reversible and irreversible microstructural changes within the corticospinal tract in idiopathic normal pressure hydrocephalus. Neuroimage Clin 14：663-671, 2017

14）Irie R, et al：Neurite orientation dispersion and density imaging for evaluation of corticospinal tract in idiopathic normal pressure hydrocephalus. Jpn J Radiol 35：25-30, 2017

15）Saito A, et al：Ventricular volumetry and free-water corrected diffusion tensor imaging of the anterior thalamic radiation in idiopathic normal pressure hydrocephalus. J Neuroradiol 47：312-37, 2020

16）Goto M, et al：Detection of lesions depends on the DARTEL template used in group comparisons with voxel-based morphometry. Acta Radiol 61：236-243, 2020

17）Mori E, et al；Japanese Society of Normal Pressure Hydrocephalus：Guidelines for management of idiopathic normal pressure hydrocephalus：second edition. Neurol Med Chir（Tokyo）52：775-809, 2012

18）Kazui H, et al；SINPHONI-2 Investigators：Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus（SINPHONI-2）：an open-label randomised trial. Lancet Neurol 14：585-594, 2015

19）Miyajima M, et al；SINPHONI-2 Investigators：One-year outcome in patients with idiopathic normal-pressure hydrocephalus：comparison of lumboperitoneal shunt to ventriculoperitoneal shunt. J Neurosurg 125：1483-1492, 2016

20）Kuriyama N, et al：Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan：epidemiological and clinical characteristics. Brain Behav 7：e00635, 2017

21）Nakajima M, et al；The research committee of idiopathic normal pressure hydrocephalus：Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus（Third Edition）：endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir（Tokyo）61：63-97, 2021

22）Yamada S, et al；SINPHONI-2 Investigators：Disability risk or unimproved symptoms following shunt surgery in patients with idiopathic normal-pressure hydrocephalus：post hoc analysis of SINPHONI-2. J Neurosurg 126：2002-2009, 2017

23）Ishikawa M, et al：Early and delayed assessments of quantitative gait measures to improve the tap test as a predictor of shunt effectiveness in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 13：20, 2016

24）Matsuoka T, et al：Characteristics of cognitive function evaluation using the Montreal cognitive assessment in a cerebrospinal fluid tap test in patients with idiopathic normal pressure hydrocephalus. Clin Neurol Neurosurg 186：105524, 2019

25）Kubo Y, et al：Validation of grading scale for evaluating symptoms of idiopathic normal-pressure hydrocephalus. Dement Geriatr Cogn Disord 25：37-45, 2008

26）Podsiadlo D, Richardson S：The timed “Up ＆ Go”：a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39：142-148, 1991

27）Walchenbach R, et al：The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 72：503-506, 2002

28）Akiguchi I, et al：Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol 255：1392-1399, 2008

29）Hellström P, et al：The neuropsychology of iNPH：findings and evaluation of tests in the European multicentre study. Clin Neurol Neurosurg 114：130-134, 2012

30）Hellström P, et al：A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand 126：229-237, 2012

31）Wikkelsø C, et al；European iNPH Multicentre Study Group：The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 84：562-568, 2013

32）Yamada S, et al：Timed up and go test at tap test and shunt surgery in idiopathic normal pressure hydrocephalus. Neurol Clin Pract 7：98-108, 2017

33）Nakajima M, et al：Tap test can predict cognitive improvement in patients with iNPH-results from the multicenter prospective studies SINPHONI-1 and -2. Front Neurol 12：769216, 2021

34）Haan J, Thomeer RT：Predictive value of temporary external lumbar drainage in normal pressure hydrocephalus. Neurosurgery 22：388-391, 1988

35）Børgesen SE：Conductance to outflow of CSF in normal pressure hydrocephalus. Acta Neurochir（Wien）71：1-45, 1984

36）Malm J, et al：Cerebrospinal fluid shunt dynamics in patients with idiopathic adult hydrocephalus syndrome. J Neurol Neurosurg Psychiatry 58：715-723, 1995

37）Malm J, et al：The predictive value of cerebrospinal fluid dynamic tests in patients with the idiopathic adult hydrocephalus syndrome. Arch Neurol 52：783-789, 1995

38）Miyajima M, et al：Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol 20：236-242, 2013

39）Moriya M, et al：Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade. PLoS One 10：e0119973, 2015

40）Nakajima M, et al：Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci 357：88-95, 2015

41）Akiba C, et al：Change of amyloid-β 1-42 toxic conformer ratio after cerebrospinal fluid diversion predicts long-term cognitive outcome in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 63：989-1002, 2018

42）Jeppsson A, et al：Idiopathic normal-pressure hydrocephalus：pathophysiology and diagnosis by CSF biomarkers. Neurology 80：1385-1392, 2013

43）Jeppsson A, et al：CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics. J Neurol Neurosurg Psychiatry 90：1117-1123, 2019

44）Kawamura K, et al：Cerebrospinal fluid amyloid-β oligomer levels in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 83：179-190, 2021

45）Kokkinou M, et al：Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting. Cochrane Database Syst Rev 2：CD010945, 2021

46）Nakajima M, et al：Brain localization of leucine-rich α2-glycoprotein and its role. Acta Neurochir Suppl 113：97-101, 2012

47）Miyajima M, et al：Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex. PLoS One 8：e74453, 2013

48）Vanninen A, et al：Elevated CSF LRG and decreased Alzheimer's disease biomarkers in idiopathic normal pressure hydrocephalus. J Clin Med 10：1105, 2021

49）Nakajima M, et al：Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus. Eur J Neurol 28：389-400, 2021

50）Nagata Y, et al：PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus. Mol Med Rep 16：3034-3040, 2017

51）Mao C, et al：Cerebrospinal fluid Alzheimer's biomarkers and neurofilament light profile of idiopathic normal pressure hydrocephalus in China：a PUMCH Cohort Study. Neurodegener Dis 20：165-172, 2020

52）Pfanner T, et al：Cerebrospinal fluid biomarkers as predictors of shunt response in idiopathic normal pressure hydrocephalus：a systematic review. Can J Neurol Sci 45：3-10, 2018

53）Agren-Wilsson A, et al：CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand 116：333-339, 2007

54）Rohrer JD, et al：Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology 87：1329-1336, 2016

55）Sun Q, et al：CSF neurofilament light chain elevation predicts ALS severity and progression. Front Neurol 11：919, 2020

56）Gaetani L, et al：Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 90：870-881, 2019

57）Nakajima M, et al：Preoperative phosphorylated Tau concentration in the cerebrospinal fluid can predict cognitive function three years after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 66：319-331, 2018

58）Koivisto AM, et al；Kuopio NPH Registry（www.uef.finph）：Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus. Neurosurgery 72：1-8；discussion 8, 2013

59）Nagata Y, et al：Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort. Biomark Res 6：5, 2018

C］PIB-PET imaging in idiopathic normal pressure hydrocephalus in relation to confirmed amyloid-β plaques and Tau in brain biopsies. J Alzheimers Dis 64：171-179, 2018

61）Kamohara C, et al：Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus. Acta Neurol Scand 142：623-631, 2020

62）Sakurai A, et al：Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus. J Neurol, 2021 ［Online ahead of print］　doi：10.1007/s00415-021-10778-1

63）Ishii K：Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus. Jpn J Radiol 38：64-76, 2020

64）Pozzi NG, et al：Striatal dopamine deficit and motor impairment in idiopathic normal pressure hydrocephalus. Mov Disord 36：124-132, 2021

65）Provost JS, et al：Neuroimaging studies of the striatum in cognition Part Ⅰ：healthy individuals. Front Syst Neurosci 9：140, 2015

66）Molde K, et al：Parkinsonian symptoms in normal pressure hydrocephalus：a population-based study. J Neurol 264：2141-2148, 2017

67）Malm J, et al：Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS 10：22, 2013